Elis has been given a Buy rating by UBS, with a target price of €27. The investment bank's decision is based on the company's resilience and strong leadership.

UBS also mentions that Elis's strategy to reduce debt provides opportunities for shareholder returns and potential growth through mergers and acquisitions. This positive outlook reflects confidence in Elis's ability to effectively navigate market challenges.

Overall, UBS's Buy rating and target price of €27 demonstrate their confidence in Elis's resilience, strong leadership, and strategic initiatives to reduce debt and drive growth.